Gilead Sciences, Inc. (GILD) NASDAQ

123.40

+0.84(+0.69%)

Updated at November 12 04:00PM

Currency In USD

Valuation

Market Cap115.19B
Enterprise Value131.91B
P/E Ratio18.91
PEG Ratio0.66
Price/Sales Ratio5.26
Price/Book Ratio7.15
Enterprise/Revenue5.04
Enterprise/EBITDA11.51

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterSeptember 30, 2025

Profitability

Profit Margin0.28
Operating Margin0.36

Management Effectiveness

Return On Assets0.14
Return On Equity0.41

Income Statement

Revenue28.75B
Revenue/Share23.4
Gross Profit22.5B
EBITDA4.43B
Net Income480M
Diluted EPS0.38

Balance Sheet

Total Cash7.35B
Total Cash/Share7.53
Total Debt24.94B
Total Debt/Equity0.13
Current Ratio1.53
Book Value Per Share17.26

Price History

52-Week Change33.22
52-Week High124.87
52-Week Low86.08
Moving Average 50 Days116.79
Moving Average 200 Days110.82

Statistics

Average Volume6.98M
Shares Outstanding1.24B
% Held by Institutions82.52

Dividend And Splits

Trailing Annual Dividend Rate3.14
Trailing Annual Dividend Yield2.54
Payout Ratio0.61
Last Split Factor2:1
Last Split DateJanuary 28, 2013